Overview
The August 26 scan recorded 165 total 20-week breakout signals, split between 94 bullish (dollar_20_wk + pct_20_wk) and 71 bearish (dollar_d20_wk + pct_d20_wk) moves. The 57% bullish tilt places this session in the balanced-to-mildly-bullish zone rather than a decisive institutional buying wave, consistent with the broader Cautious SA Regime where breadth sits at 55.2% above SMA-40 and sentiment reads Bullish/Neutral.
Leadership is concentrated in Communication Services (3.2% ATR), Health Care (3.1%), and Energy (2.3%), while Technology (-0.9%) and Utilities (-1.8%) lag. Notably, the bullish 20-week list is dominated by leveraged crypto-linked ETNs (CRCG, CRCA, CONX, CONL, COIG, XRPT, ETHT) with near-zero institutional fund ownership — a speculative retail-driven pattern rather than broad institutional accumulation.
Quality Score: 3/5. Under the Cautious regime rule, only the highest-conviction setups score 4+. Thin institutional participation (mostly 0-1 funds) across the bullish leaders and extreme ADR%/volatility profiles (10-20% daily ranges) cap conviction despite strong percentage moves.
Top 5 Bullish Picks
BRNX ($6.24) — Energy / Energy-Alternative
Weekly Momentum: BRNX surged on a pct_20_wk breakout with relative volume of 2.1x average (1,234,427 vs 589,630 shares), an ATR multiple of 2.95, and 202.7% gain above its 52-week low, signaling strong speculative demand in the alternative energy niche.
| Level | Price |
|---|---|
| Stop-Loss (1.5x ATR) | $4.92 |
| Entry | $6.24 |
| Target 1 (2x ATR) | $8.00 |
| Target 2 (3x ATR) | $8.88 |
Institutional Interest: 1 fund holding, 0.3% of shares outstanding — early-stage institutional footprint, no bucket classification.
VOGX ($32.88) — Medical / Development Biotech
Weekly Momentum: VOGX is trading just 7.4% off its 52-week high after a 153.9% advance from its low, with an ATR multiple of 3.45 confirming genuine trend expansion despite below-average relative volume (0.8x).
| Level | Price |
|---|---|
| Stop-Loss (1.5x ATR) | $26.40 |
| Entry | $32.88 |
| Target 1 (2x ATR) | $41.52 |
| Target 2 (3x ATR) | $45.84 |
Institutional Interest: 0 funds currently holding; classified in bucket_0_youth_ipo_less_5yrs, indicating a young, pre-institutional listing with speculative biotech risk.
ETHT ($17.12) — ETF/ETN/CEF / Finance-ETF
Weekly Momentum: This Ethereum-linked leveraged product posted an extreme 12.31 ATR multiple move, though only 42.2% above its 52-week low and still 85.7% below its 52-week high, reflecting high volatility crypto-beta exposure rather than a sustained institutional trend.
| Level | Price |
|---|---|
| Stop-Loss (1.5x ATR) | $15.79 |
| Entry | $17.12 |
| Target 1 (2x ATR) | $18.90 |
| Target 2 (3x ATR) | $19.79 |
Institutional Interest: 0 funds — pure retail/derivative product flow, no bucket classification.
XRPT ($35.16) — ETF/ETN/CEF / Finance-ETF
Weekly Momentum: XRPT led relative volume among the group at 2.3x average (431,439 vs 185,880 shares), with an ATR multiple of 5.11 and 85.4% gain off its 52-week low, signaling accelerating crypto-linked speculative interest.
| Level | Price |
|---|---|
| Stop-Loss (1.5x ATR) | $30.59 |
| Entry | $35.16 |
| Target 1 (2x ATR) | $41.26 |
| Target 2 (3x ATR) | $44.31 |
Institutional Interest: 0 funds holding, no bucket data — high-risk, retail-driven vehicle.
CRCG ($15.74) — ETF/ETN/CEF / Finance-ETF
Weekly Momentum: CRCG advanced on near-in-line volume (3,390,711 vs 3,425,750 avg) with a solid 4.38 ATR multiple and 130.8% gain off its 52-week low, one of the more liquid names in the leveraged-crypto ETN cohort.
| Level | Price |
|---|---|
| Stop-Loss (1.5x ATR) | $13.04 |
| Entry | $15.74 |
| Target 1 (2x ATR) | $19.34 |
| Target 2 (3x ATR) | $21.14 |
Institutional Interest: 0 funds — no institutional footprint yet, no bucket assigned.
Bearish Alerts
Bearish signals remain material at 71 total. CBRS ($182.15, Chips/Semiconductors) shows the heaviest institutional exposure among bearish names with 401 funds holding, now 52.9% below its 52-week high — a distribution signal worth monitoring in the semiconductor space. MOG-A ($384.11, Aerospace & Defense) is down on light relative volume (0.7x), suggesting controlled profit-taking rather than panic selling. CNXU and LITZ both show elevated relative volume (2.0x and 2.8x) with negative ATR multiples, indicating active selling pressure in biotech and leveraged ETN products alike. MRNX stands out with a high positive ATR multiple (6.28) despite bearish classification, warranting caution on signal interpretation.
Sector Theme
Cross-sector momentum favors Communication Services, Health Care, and Energy per ATR% leadership, while Technology, Industrials, and Utilities lag. The bullish 20-week list, however, is heavily skewed toward ETF/ETN/CEF crypto-leveraged products (7 of top 10 signals), suggesting speculative crypto-beta rotation is outweighing traditional sector leadership on this scan date.
Institutional Summary
Institutional participation across bullish leaders is minimal: CBRS (bearish, 401 funds) is the only name with substantial institutional ownership in this dataset. Among bullish picks, only BRNX shows any institutional footprint (1 fund, 0.3%). This near-total absence of fund accumulation in the bullish cohort reinforces the Cautious regime’s call for selectivity — traders should treat these as high-volatility momentum trades rather than institutionally-backed accumulation setups.